AUTOCRINE AND PARACRINE REGULATION OF NEOPLASTIC CELL-GROWTH IN HAIRY-CELL LEUKEMIA

被引:11
作者
SCHMID, M
PORZSOLT, F
机构
[1] Department Of Internal Medicine III, Haematology and Oncology, University of Ulm, Ulm/Donau
关键词
AUTOCRINE; PARACRINE; REGULATION; CELL GROWTH; NEOPLASIAS; HAIRY CELL LEUKEMIA;
D O I
10.3109/10428199509056850
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hairy cell leukemia (HCL), a rare haematological disorder of B-cell origin, mainly presents with bone marrow infiltration, haematopoietic insufficiency, and splenomegaly. In some cases, osteolytic lesions can be observed. Many of these clinical features, especially haematopoietic insufficiency and osteolytic lesions are likely to be caused by soluble factors, such as cytokines. There is evidence that these factors are produced by the malignant hairy cells themselves, suggesting a paracrine pathway. The importance of autocrine as well as paracrine growth loops in growth regulation of HCL-cells is supported by a series of excellent studies, performed within the last few years. It could be clearly shown that cytokines are involved in this autocrine and paracrine regulatory process. The most important cytokines which should be mentioned in this respect are tumor necrosis factor alpha. (TNE alpha). Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-6 (IL-6) and B-cell-growth factor (BCGF). The role of other factors such as viruses and oncogenes remains rather unclear. Nevertheless, recent data suggest that the c-fms, which encodes for the macrophage colony stimulating factor (M-CSF) may be involved in the pathophysiological control of HCL growth.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 133 条
  • [1] Bouroncle B.A., Wiseman B.K., Doan C.A., Leukemic reticuloendotheliosis, Blood., 13, pp. 609-630, (1958)
  • [2] Schrek R., Donelli W.J., Hairy cells in blood in lym-phoreticular neoplastic disease and flagellated cells of normal lymph nodes, Blood, 27, pp. 199-211, (1966)
  • [3] Mulligan S.P., Travade P., Matutes E., Dearden C., Visser L., Poppema S., Catovsky D., B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines a activation antigen on normal CD8+ T-cells, Blood, 76, pp. 959-964, (1990)
  • [4] Wormsley S.B., Baird S.M., Gadol N., Rai K.R., Sobol R.E., Characteristics of CDllc+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemias immunophenotypes, Blood, 76, pp. 123-130, (1990)
  • [5] Sun T., Susin M., Shevde N., Teichberg S., Hybrid form of hairy cell leukemia and chronic lymphocytic leukemia, Hematol. Oncol., 8, pp. 283-294, (1990)
  • [6] Hanson C.A., Gribbin T.E., Schnitzer B., Schlegelmilch J.A., Mitchel B.S., Stoolman L.M., CDI lc (Leu-M5) expression characterizes a B-cell lymphoproliferative disorder with features of both chronic lymphocytic and hairy cell leukemia, Blood., 76, pp. 2360-2367, (1990)
  • [7] Browser T.M., Dunbar C.E., Nienhuis A.W., Private and public autocrine loops in neoplastic cells, Cancer cells, 1, pp. 9-17, (1989)
  • [8] Lang R.A., Burgess A.W., Autocrine growth factors and tumorigenic transformation, Immunol Today, 11, pp. 244-249, (1990)
  • [9] Aaronson S.A., Growth factors and cancer, Science, 254, pp. 1146-1153, (1991)
  • [10] Cross M., Dexter T.M., Growth factors in development, transformation and tumorigenesis, Cell, 64, pp. 271-280, (1991)